Profile | GDS4284 / 221698_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1246.18 | 77 |
GSM687648 | Patient 402 control | 6207.98 | 95 |
GSM687653 | Patient 403 control | 946.252 | 74 |
GSM687658 | Patient 404 control | 11392.7 | 98 |
GSM687663 | Patient 411 control | 7768.04 | 96 |
GSM687668 | Patient 422 control | 3988.29 | 91 |
GSM687673 | Patient 424 control | 5037.06 | 93 |
GSM687678 | Patient 425 control | 5044.09 | 94 |
GSM687683 | Patient 427 control | 3309.8 | 90 |
GSM687688 | Patient 428 control | 1136.51 | 76 |
GSM687695 | Patient 441 control | 28557.2 | 99 |
GSM687699 | Patient 443 control | 8805.71 | 97 |
GSM687704 | Patient 444 control | 976.33 | 74 |
GSM687707 | Patient 448 control | 1557.36 | 81 |
GSM687712 | Patient 449 control | 1784.45 | 82 |
GSM687719 | Patient 450 control | 6850.28 | 95 |
GSM687724 | Patient 451 control | 950.161 | 74 |
GSM687728 | Patient 452 control | 28833.1 | 99 |
GSM687646 | Patient 401 treated 24h | 852.248 | 71 |
GSM687649 | Patient 402 treated 24h | 7151.69 | 96 |
GSM687665 | Patient 411 treated 24h | 7782.51 | 96 |
GSM687651 | Patient 402 treated 4 weeks | 3796.16 | 91 |
GSM687667 | Patient 411 treated 4 weeks | 5110.51 | 93 |
GSM687670 | Patient 422 treated 24h | 4068.53 | 92 |
GSM687671 | Patient 422 treated 4 weeks | 2679.51 | 87 |
GSM687654 | Patient 403 treated 24h | 1524.74 | 80 |
GSM687675 | Patient 424 treated 24h | 5927.24 | 95 |
GSM687685 | Patient 427 treated 24h | 4978.46 | 93 |
GSM687656 | Patient 403 treated 4 weeks | 1006.44 | 74 |
GSM687677 | Patient 424 treated 4 weeks | 2179.45 | 85 |
GSM687687 | Patient 427 treated 4 weeks | 1290.47 | 77 |
GSM687692 | Patient 428 treated 4h | 2240.07 | 85 |
GSM687716 | Patient 449 treated 4h | 1092.64 | 76 |
GSM687722 | Patient 450 treated 4h | 6347.22 | 95 |
GSM687680 | Patient 425 treated 24h | 5711.7 | 94 |
GSM687690 | Patient 428 treated 24h | 3768.03 | 91 |
GSM687700 | Patient 443 treated 24h | 13535 | 98 |
GSM687705 | Patient 444 treated 24h | 1727.08 | 82 |
GSM687714 | Patient 449 treated 24h | 2269.21 | 85 |
GSM687721 | Patient 450 treated 24h | 8537.74 | 96 |
GSM687682 | Patient 425 treated 4 weeks | 7783.66 | 96 |
GSM687694 | Patient 428 treated 4 weeks | 2149.6 | 84 |
GSM687702 | Patient 443 treated 4 weeks | 4929.08 | 93 |
GSM687718 | Patient 449 treated 4 weeks | 872.768 | 72 |
GSM687723 | Patient 450 treated 4 weeks | 2967.79 | 89 |
GSM687661 | Patient 404 treated 4h | 6936.5 | 95 |
GSM687710 | Patient 448 treated 4h | 1433.5 | 80 |
GSM687726 | Patient 451 treated 4h | 768.302 | 70 |
GSM687730 | Patient 452 treated 4h | 9673.71 | 97 |
GSM687660 | Patient 404 treated 24h | 32199.3 | 99 |
GSM687697 | Patient 441 treated 24h | 27331.8 | 99 |
GSM687709 | Patient 448 treated 24h | 1658.54 | 82 |
GSM687725 | Patient 451 treated 24h | 766.788 | 70 |
GSM687729 | Patient 452 treated 24h | 37381.8 | 99 |
GSM687727 | Patient 451 treated 4 weeks | 1019.29 | 74 |
GSM687731 | Patient 452 treated 4 weeks | 20082.4 | 99 |